Professor Andrea Brancale
Prosiectau fel Prif Ymchwiliwr
1 o 12
- ADC targets from in-silico high throughput screening identification into target validation (01.10.2016 - 21.02.2019)
- ADME/toxicology analyses of lead Schistosoma mansoni histone methyltransferase (HMT) inhibitors (30.06.2018 - 21.02.2019)
- Advanced Therapeutics Wales (01.07.2018 - 21.02.2019)
- All Wales antivirals discovery and development platform (01.01.2016 - 31.03.2019)
- An event to explore Intellectual Property Rights (01.01.2018 - 04.01.2019)
Prosiectau fel Cyd-Ymchwiliwr
1 o 9
- Advancing analogues of a novel cFlip inhibitor which sensitises breast cancer cells and stem cells to TRAIL (01.10.2015 - 30.09.2016)
- An innovative approach to new antimicrobial drugs (01.10.2014 - 30.09.2017)
- A novel treatment for blindness caused by autosomal dominant optic atrophy (17.10.2017 - 28.02.2019)
- Bioengineering of a dual-target therapeutic to modulate a pro-inflammatory and pro-coagulant pathology (01.02.2019 - 30.06.2021)
- Cancer drug discovery: Targeting protein - protein interactions (01.10.2007 - 01.10.2010)
Thomson Reuters Deutschland GmbH
Zur Giesserei 2
D-76227 Karlsruhe | Germany